A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections
Objective: A Canadian multicentre clinical trial in the treatment of intra-abdominal and pelvic infections to compare the efficacy and safety of monotherapy using imipenem-cilastatin (imipenem) (500 mg intravenously every 6 h) versus combination therapy with clindamycin/tobramycin (clindamycin 600 m...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1993-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1993/567478 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849411499794104320 |
|---|---|
| author | Lionel A Mandell Pierre L Turgeon Allan R Ronalds The Canadian Clinical Trials Group |
| author_facet | Lionel A Mandell Pierre L Turgeon Allan R Ronalds The Canadian Clinical Trials Group |
| author_sort | Lionel A Mandell |
| collection | DOAJ |
| description | Objective: A Canadian multicentre clinical trial in the treatment of intra-abdominal and pelvic infections to compare the efficacy and safety of monotherapy using imipenem-cilastatin (imipenem) (500 mg intravenously every 6 h) versus combination therapy with clindamycin/tobramycin (clindamycin 600 mg intravenously every 6 h and tobramycin 1.7 mg/kg intravenously every 8 h). |
| format | Article |
| id | doaj-art-5d69ca7527554332822f28332e68ba1a |
| institution | Kabale University |
| issn | 1180-2332 |
| language | English |
| publishDate | 1993-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases |
| spelling | doaj-art-5d69ca7527554332822f28332e68ba1a2025-08-20T03:34:45ZengWileyCanadian Journal of Infectious Diseases1180-23321993-01-014527928710.1155/1993/567478A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic InfectionsLionel A Mandell0Pierre L Turgeon1Allan R Ronalds2The Canadian Clinical Trials GroupDivision of Infectious Diseases, Department of Medicine, Henderson General Hospital and McMaster University, Hamilton, Ontario, CanadaDivision of Infectious Diseases, Department of Medicine, Henderson General Hospital and McMaster University, Hamilton, Ontario, CanadaDepartment of Medicine and Medical Microbiology, The University of Manitoba, Winnipeg, Manitoba, CanadaObjective: A Canadian multicentre clinical trial in the treatment of intra-abdominal and pelvic infections to compare the efficacy and safety of monotherapy using imipenem-cilastatin (imipenem) (500 mg intravenously every 6 h) versus combination therapy with clindamycin/tobramycin (clindamycin 600 mg intravenously every 6 h and tobramycin 1.7 mg/kg intravenously every 8 h).http://dx.doi.org/10.1155/1993/567478 |
| spellingShingle | Lionel A Mandell Pierre L Turgeon Allan R Ronalds The Canadian Clinical Trials Group A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections Canadian Journal of Infectious Diseases |
| title | A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections |
| title_full | A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections |
| title_fullStr | A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections |
| title_full_unstemmed | A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections |
| title_short | A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections |
| title_sort | prospective randomized trial of imipenem cilastatin versus clindamycin tobramycin in the treatmentof intra abdominal and pelvic infections |
| url | http://dx.doi.org/10.1155/1993/567478 |
| work_keys_str_mv | AT lionelamandell aprospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections AT pierrelturgeon aprospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections AT allanrronalds aprospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections AT thecanadianclinicaltrialsgroup aprospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections AT lionelamandell prospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections AT pierrelturgeon prospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections AT allanrronalds prospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections AT thecanadianclinicaltrialsgroup prospectiverandomizedtrialofimipenemcilastatinversusclindamycintobramycininthetreatmentofintraabdominalandpelvicinfections |